Middletown, DE -- (SBWIRE) -- 09/07/2013 -- VipStockReports.com screens the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way. Today our focus is on: XOMA Corp(NASDAQ:XOMA), MiMedx Group Inc(NASDAQ:MDXG), Allscripts Healthcare Solutions Inc(NASDAQ:MDRX), Nektar Therapeutics(NASDAQ:NKTR).
XOMA Corp(NASDAQ:XOMA) ended higher +2.61% and complete the day at $4.71. The total number of shares changed hands during the day was 1.12 million. After opening at $4.61, the stock hit as high as $4.78. However, it traded between $2.37 and $5.53 over the last twelve months.
XOMA Corporation discovers and develops antibody-based therapeutics in the United States, Europe, and the Asia Pacific. The company offers ACEON, an angiotensin converting enzyme inhibitor. Its proprietary products include gevokizumab, a human engineering (HE) antibody to interleukin-1 beta, which is Phase III studies for non-infectious uveitis and Behçet?s uveitis
For How Long XOMA will Fight for Profitability? Read This Trend Analysis report
MiMedx Group Inc(NASDAQ:MDXG) closed yesterday at $4.20, a -8.89% decrease. Around 1.10 million shares were traded, beating an-average trading volume of 560,101 shares. The company is now valued at around $404.77 million.
MiMedx Group, Inc., together with its subsidiaries, operates as an integrated developer, manufacturer, and marketer of patent protected regenerative biomaterial products and allografts processed from human amniotic membranes. Its biomaterial platform technologies include HydroFix and CollaFix device technologies
Has MDXG Found The Bottom And Ready To Gain Momentum? Find Out Here
Allscripts Healthcare Solutions Inc(NASDAQ:MDRX) moved -0.28 percent lower at $14.41 and traded between $14.22 and $14.51 after opening the day at $14.50. Its performance over the last five days remained -6.18%, which stands at -10.39% for a month. Going back further than one month, 1-year performance after recent close was 52.97%.
Allscripts Healthcare Solutions, Inc. provides clinical, financial, connectivity, and information solutions and related professional services to hospitals, physicians, and post-acute organizations primarily in the United States and Canada
Why Should Investors Buy MDRX After the Recent Fall? Just Go Here and Find Out
Nektar Therapeutics(NASDAQ:NKTR) shares rose, gaining +1.40 percent to close at $13.04. The stock is up around 75.98% this year and 51.98% for the last 12 months. Around 1.07million shares changed hands yesterday, lower from an-average trading volume of 1.15 million shares.
Nektar Therapeutics, a clinical-stage biopharmaceutical company, engages in developing a pipeline of drug candidates that utilize its PEGylation and polymer conjugate technology platforms. Its product pipeline consists of drug candidates in various therapeutic areas, including oncology, pain, anti-infectives, and immunology. The company?s drug candidates in clinical development stage comprise naloxegol, an opioid antagonist that is in Phase 3 clinical trail for the treatment of opioid-induced constipation
Why Should Investors Buy NKTR After The Recent Gain? Just Go Here and Find Out
We screen the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Once we find the 'Next Hot Penny Stock' with Monster Upside Potential we immediately Email it to you in our detailed VIP Report so you can Beat Rest of the Crowd!!
Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way.
VipstockReports.com newsletters and website: The disclaimer is to be read entirely and fully understood before using our website, or joining our newsletter email list. Never invest into a stock discussed on this website or the Vipstockalerts.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.
VipStockReports.com and any affiliates and information providers make no implied or express warranties on the information provided. Please verify quotes with your financial advisor before making investment decisions. This is not to be construed as a solicitation to buy or sell securities. As with any stock, the featured companies profiled on the VipstockReports.com web site and/or newsletter involve a high degree of volatility and risk, and all investors should know that they may lose a portion of or all of their investment if they decide to purchase any stocks.
Read Full Disclaimer at: http://www.vipstockreports.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)